SCI Abstract

search
Expansion cohorts in phase 1 oncology trials: a systematic review of their design, implementation and outcomes
Expansion cohorts in phase 1 oncology trials: a systematic review of their design, implementation and outcomes
The urgent need for drug development for cancer patients and the complexity of novel therapies have led to the increasing ...
Response to ‘Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer’
Division of Surgical Oncology, Department of Surgery, University of Colorado, Anschutz Medical Campus, Aurora, CO, USAThom...
ULK1 promotes oxaliplatin resistance of colon cancer via phosphorylation of Bax S184
ULK1 promotes oxaliplatin resistance of colon cancer via phosphorylation of Bax S184
Oxaliplatin resistance continues to undermine therapeutic outcomes in colon cancer (CC). Recent investigations point to un...
Long-term atmospheric exposure to particulate matter and breast cancer risk: findings from a nested case-control study in France
Long-term atmospheric exposure to particulate matter and breast cancer risk: findings from a nested case-control study in France
Airborne particulate matter (PM) is a complex mixture of particles thought to be associated with a range of adverse health...
Tumour immune contexture and immune evasion in sporadic and Lynch syndrome-associated microsatellite unstable colorectal cancers
Tumour immune contexture and immune evasion in sporadic and Lynch syndrome-associated microsatellite unstable colorectal cancers
The high mutational burden in microsatellite unstable colorectal cancers (MSI CRCs) results in high immunogenicity, yet re...
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples
Whole Transcriptome Sequencing (WTS) is a comprehensive alternative to targeted panels for detecting gene fusions and spli...
An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells
An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells
Cutaneous angiosarcoma (CAS) is a life-threatening neoplasm with a 5-year survival rate of under 40% in advanced cases. As...
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma
Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) remains the most lethal cancer. While DNA damaging agents such as platinum and PAR...
Cyst fluid ctDNA as a biomarker for genetic profiling and treatment monitoring in cystic brain metastases
Cyst fluid ctDNA as a biomarker for genetic profiling and treatment monitoring in cystic brain metastases
Cystic brain metastases (CBM) present significant clinical challenges due to their heterogeneity and the limitations of cu...
Spatial omics technology potentially promotes the progress of tumor immunotherapy
Spatial omics technology potentially promotes the progress of tumor immunotherapy
Immunotherapy has become an indispensable modality in the treatment of cancer, yet challenges such as resistance and subst...
Ending nuclear weapons, before they end us
This May, the World Health Assembly (WHA) will vote on re-establishing a man...
EHMT1 mediates cellular motility in embryonal rhabdomyosarcoma by activating SOX8 expression
EHMT1 mediates cellular motility in embryonal rhabdomyosarcoma by activating SOX8 expression
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. When metastatic, survival of children with RMS is...
Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma
Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma
Gut microbial dysbiosis is implicated in chronic liver disease and hepatocellular carcinoma (HCC), but the role of microbi...
Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors
Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors
Inhibition of mutant KRAS challenged cancer research for decades. Recently, allele-specific inhibitors were approved for t...
wMKL: multi-omics data integration enables novel cancer subtype identification via weight-boosted multi-kernel learning
wMKL: multi-omics data integration enables novel cancer subtype identification via weight-boosted multi-kernel learning
Cancer is a heterogeneous disease driven by complex molecular alterations. Cancer subtypes determined from multi-omics dat...
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20
The repurposing of FDA-approved drugs for anti-cancer therapies is appealing due to their established safety profiles and ...
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) treatment is largely based on a ‘one-drug-fits-all’ strategy in patients with s...
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells
5-Fluorouracil (5-FU) remains a core component of systemic therapy for colorectal cancer (CRC). However, response rates re...
The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit
The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit
Understanding relationships between presenting symptoms and subsequently diagnosed cancers can inform symptom awareness ca...
Epithelial ovarian cancer survival by race and ethnicity in an equal-access healthcare population
Previous studies in the general population observed that compared with non-Hispanic White women, Pacific Islander and Blac...
Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study
Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study
Many breast cancer survivors experience anxiety related to dying from their disease even if it is detected at an early sta...
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Alterations of FLT3 are among the most common driver events in acute leukaemia with important clinical implications, since...
Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer
Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer
The determinants of metastasis in mismatch repair deficiency with high levels of microsatellite instability (MSI-H) in col...